BofA Securities Reiterates Buy on CMOC as H1 Profit Exceeds Forecasts

Market Watcher
Jul 15, 2025

BofA Securities has reaffirmed its "Buy" rating on China Molybdenum (03993.HK) with an H-share target price of HK$8.50, citing stronger-than-expected first-half performance. The firm's management projects second-quarter production costs will remain stable quarter-over-quarter but decline year-over-year, with TFM copper production costs ranging between $5,500-$6,000/ton and KFM costs at $3,000-$3,500/ton.

CMOC's preliminary financial results indicate H1 net profit of 8.2-9.1 billion yuan, representing 51%-68% year-over-year growth that aligns with BofA's projections. This achievement reaches 58% of full-year market consensus estimates. Second-quarter net profit is estimated at 4.25-5.15 billion yuan, marking 27%-54% YoY and 8%-31% QoQ growth.

Profit growth drivers include: - Copper and cobalt price movements: Q2 copper averaged $9,538/ton (down 2% YoY, up 2% QoQ) while cobalt hydroxide surged 61% QoQ to 188,000 yuan/ton - Production expansion: H1 copper output reached 354,000 tons (+13% YoY) and cobalt production hit 61,000 tons (+13% YoY) - Q2 copper production reached 183,000 tons (+10% YoY, +7% QoQ), translating to annualized output exceeding 700,000 tons - surpassing the 600,000-660,000 ton annual guidance - Cobalt output maintained at 30,600 tons (+6% YoY, +1% QoQ) despite export restrictions in the Democratic Republic of Congo

Continuous technological upgrades enabled this production outperformance, with BofA emphasizing CMOC's operational resilience amid market challenges.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10